Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03477968 · ClinicalTrials.gov registry record
ThRombosis ExclUsion STudy
A clinical trial, sponsored by Diagnostica Stago.
- Terminated
- Registry status
- 5,935
- Enrollment target
NCT03477968 is a clinical trial that was terminated before completion, run by Diagnostica Stago. The registered enrollment target is 5,935 participants.
The verdict
NCT03477968 was terminated before completion, sponsored by Diagnostica Stago.
- TERMINATED
- Registry status
- 5,935 participants
- Enrollment target
Study Summary
Primary objective: To demonstrate the ability of STA® - Liatest® D-Di XL combined with a clinical PreTest Probability (PTP) to safely exclude pulmonary embolism (PE) and deep venous thrombosis (DVT) as measured by Negative Predictive Value (NPV) and sensitivity. Secondary objectives: 1. To estimate additional STA® - Liatest® D-Di XL accuracy parameters, including specificity and positive predictive value (PPV) 2. To constitute a plasma bank to be used for future studies with other DDi assays under development by Stago.
Interventions
- DIAGNOSTIC_TEST DDimer test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,935 participants |
| Start Date | 2018-06-25 |
| Est. Completion | 2024-09-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03477968
The ClinicalTrials.gov registry entry for NCT03477968 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 5,935 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Diagnostica Stago, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DDimer test is the first listed.
NCT03477968 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03477968 about?
NCT03477968 is a clinical study titled "ThRombosis ExclUsion STudy". Primary objective: To demonstrate the ability of STA® - Liatest® D-Di XL combined with a clinical PreTest Probability (PTP) to safely exclude pulmonary embolism (PE) and deep venous thrombosis (DVT) as measured by Negative Predictive Value (NPV) and sensitivity. Secondary objectives: 1. To estimat...
What is the current status of trial NCT03477968?
This trial is currently terminated. The enrollment target is 5,935 participants. The study started on 2018-06-25. Estimated completion is 2024-09-05.
What interventions are being tested in trial NCT03477968?
The interventions under investigation include: DDimer test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03477968?
This trial is sponsored by Diagnostica Stago, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.